ClinicalTrials.Veeva

Menu

Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients

S

Saglik Bilimleri Universitesi

Status

Enrolling

Conditions

Pemphigus Vulgaris (PV)
Periodontal Diseases

Treatments

Other: Clinical Periodontal and Oral Evaluation

Study type

Observational

Funder types

Other

Identifiers

NCT07384221
2025-161

Details and patient eligibility

About

The aim of this study is to evaluate the relationship between the severity of Pemphigus Vulgaris (a chronic autoimmune skin disease) and periodontal (gum) health. Researchers will assess disease activity using the Oral Disease Severity Score (ODSS) for mouth lesions and measure serum Desmoglein 1 and 3 levels through blood tests. These findings will be compared with clinical gum measurements, such as pocket depth and attachment levels. The study intends to determine how the clinical and biochemical severity of Pemphigus Vulgaris impacts periodontal tissues and overall oral health.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years and older.
  • Clinically and histopathologically confirmed diagnosis of Pemphigus Vulgaris.
  • Presence of at least 10 natural teeth.
  • Willingness to participate and signed informed consent.

Exclusion criteria

  • Pregnancy or lactation.
  • Use of systemic antibiotics or anti-inflammatory drugs within the last 3 months.
  • Periodontal treatment received within the last 6 months.

Trial design

20 participants in 1 patient group

Pemphigus Vulgaris Group
Description:
A comprehensive oral examination including ODSS scoring and periodontal measurements (PPD, CAL, PI, GI). Additionally, serum Desmoglein 1 and 3 levels will be retrieved from the patients' medical records for biochemical correlation.
Treatment:
Other: Clinical Periodontal and Oral Evaluation

Trial contacts and locations

1

Loading...

Central trial contact

Bilkan KARA, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems